{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:23:16Z","timestamp":1794248596621,"version":"4.9.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The Wuhan Health Research Foundation","award":["No.WX21M04"],"award-info":[{"award-number":["No.WX21M04"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,21]]},"abstract":"<jats:p>\n                    Presently, the majority of investigations into the effects blood lipids on prostate cancer (PCa) primarily involve Western populations. Our study endeavors to investigate the impact of blood lipid levels on the risk of PCa among the Chinese population and to elucidate their potential association with the pathological characteristics of PCa. This study drew data from a dataset for early warning of PCa from the China National Population Health Science Data Center, encompassing 2624 patients who had undergone prostate biopsy. We utilized binary logistic regression to assess the ability of blood lipid levels to distinguish between PCa and non-PCa, as well as to differentiate clinically significant prostate cancer (csPCa) from non-PCa. Additionally, we assessed the ability of these lipid markers to predict whether the Gleason Grade (GG) would be upgraded or downgraded following radical prostatectomy compared to the biopsy GG. Furthermore, ordered multiclass logistic regression was employed to explore the relationship between these indicators and GG. In the Chinese population, triglycerides (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.004; OR: 1.344; 95% CI: 1.201\u20131.503), low-density lipoprotein cholesterol (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt; .001; OR: 1.314; 95% CI: 1.200\u20131.439), and apolipoprotein A1 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001; OR: 2.451; 95% CI: 1.714\u20133.504) were identified as independent risk factors for predicting PCa. Additionally, triglycerides (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.013; OR: 1.156; 95% CI: 1.031\u20131.295) and apolipoprotein A1 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001; OR: 2.580; 95% CI: 1.809\u20133.680) were found to be independent risk factors for predicting csPCa. Our study demonstrated a positive association between blood lipid levels and PCa risk in the Chinese population, highlighting the potential utility of blood lipids as biomarkers for PCa. In male individuals with a familial predisposition to PCa or other recognized risk factors for PCa, the assessment of blood lipid levels can be incorporated as an auxiliary biomarker in the routine health screening protocol.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000041762","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T01:11:43Z","timestamp":1743037903000},"page":"e41762","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the positive association of blood lipid levels with prostate cancer risk and their relationship to pathological features in the Chinese population"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0744-4303","authenticated-orcid":false,"given":"Qian","family":"Gui","sequence":"first","affiliation":[{"name":"Department of Urology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglian","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Urology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261109","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/dom.15077","article-title":"New insights into the treatment of obesity.","volume":"25","author":"Bl\u00fcher","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"R2-20261109","doi-asserted-by":"crossref","first-page":"424","DOI":"10.21147\/j.issn.1000-9604.2023.04.08","article-title":"Focal ablation therapy presents promising results for selectively localized prostate cancer patients.","volume":"35","author":"Feng","year":"2023","journal-title":"Chin J Cancer Res"},{"key":"R3-20261109","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/imm.13456","article-title":"Cellular landscape of tumour microenvironment in prostate cancer.","volume":"168","author":"Feng","year":"2023","journal-title":"Immunology"},{"key":"R4-20261109","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022.","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"R5-20261109","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1002\/cam4.5463","article-title":"Serum cholesterol and the risk of developing hormonally driven cancers: a narrative review.","volume":"12","author":"Murdock","year":"2023","journal-title":"Cancer Med"},{"key":"R7-20261109","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1186\/s12879-024-10003-0","article-title":"Cervical cancer screening service utilisation and related factors among women on antiretroviral therapy in public health facilities of Asella town, Ethiopia, cross-sectional study.","volume":"24","author":"Yasin","year":"2024","journal-title":"BMC Infect Dis"},{"key":"R8-20261109","doi-asserted-by":"crossref","first-page":"858479","DOI":"10.3389\/fonc.2022.858479","article-title":"Mitochondria dysfunction-mediated molecular subtypes and gene prognostic index for prostate cancer patients undergoing radical prostatectomy or radiotherapy.","volume":"12","author":"Feng","year":"2022","journal-title":"Front Oncol"},{"key":"R9-20261109","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imm.13466","article-title":"Developing an immune-related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancer.","volume":"166","author":"Feng","year":"2022","journal-title":"Immunology"},{"key":"R10-20261109","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.3390\/cancers15235565","article-title":"The role of apolipoproteins in the commonest cancers: a review.","volume":"15","author":"Darwish","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R11-20261109","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4103\/aja.aja_92_20","article-title":"Identifying the role of apolipoprotein A-I in prostate cancer.","volume":"23","author":"Wang","year":"2021","journal-title":"Asian J Androl"},{"key":"R12-20261109","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12944-021-01492-y","article-title":"Prognostic significance of preoperative serum triglycerides and high-density lipoproteins cholesterol in patients with non-small cell lung cancer: a retrospective study.","volume":"20","author":"Ma","year":"2021","journal-title":"Lipids Health Dis"},{"key":"R13-20261109","doi-asserted-by":"crossref","first-page":"1113226","DOI":"10.3389\/fonc.2023.1113226","article-title":"The association between serum lipid profile and the prostate cancer risk and aggressiveness.","volume":"13","author":"Suh","year":"2023","journal-title":"Front Oncol"},{"key":"R14-20261109","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12894-022-01120-6","article-title":"Association of triglyceride levels and prostate cancer: a Mendelian randomization study.","volume":"22","author":"Zhu","year":"2022","journal-title":"BMC Urol"},{"key":"R15-20261109","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1002\/jcp.30229","article-title":"LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway.","volume":"236","author":"Jung","year":"2021","journal-title":"J Cell Physiol"},{"key":"R16-20261109","doi-asserted-by":"crossref","first-page":"74","DOI":"10.23736\/S2724-6051.23.05454-X","article-title":"Statins may increase the risk of being diagnosed with prostate cancer.","volume":"76","author":"Brassetti","year":"2024","journal-title":"Minerva Urol Nephrol"},{"key":"R17-20261109","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1038\/s41598-022-09431-2","article-title":"The tumor volume after radical prostatectomy and its clinical impact on the prognosis of patients with localized prostate cancer.","volume":"12","author":"Yuk","year":"2022","journal-title":"Sci Rep"},{"key":"R18-20261109","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.21037\/tau-24-155","article-title":"Establishing a model predicting Gleason grade group upgrading in prostate cancer.","volume":"13","author":"Chen","year":"2024","journal-title":"Transl Androl Urol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:00:59Z","timestamp":1794247259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041762","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,21]]}}}